Activities, Bill Numbers and Titles
|
|
Client: Amgen, Inc.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $1,010.00
|
Senate Bill
|
696
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1133
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1148
|
An Act regarding Massachusetts drug price relief
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
653
|
An Act relative to prescription drug pricing
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1193
|
An Act providing for the establishment of a drug cost review commission
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1206
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1767
|
An Act increasing the land conservation tax credit
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1972
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
712
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|